Antibody Drug Discovery
NeoMab Bio, a subsidiary company of Gempharmatech, has established a comprehensive antibody discovery platform by integrating its self-developed fully-human antibody transgenic mice NeoMab™ and over 20 years of in-vivo/in-vitro experimental experience. It provides innovative technological platforms and reliable technical services for antibody drug discovery.
Our Advantages
(1) NeoMab™ has a better immune response to different categories of immunogens, resulting in high antibody diversity;
(2) High diversity of antibody molecules to meet the needs of different types of antibody discovery;
(4) Customized services to meet the needs of different customers;
(5) Integrated resources to provide efficient early antibody drug discovery services.
Our Services
Based on the fully human antibody transgenic mouse NeoMab™, NeoMab Bio can provide services run through the whole process of antibody discovery.
(1) Project design;
(2) Material preparation;
(3) Immunization;
(4) Molecular generation and screening;
(5) In-vivo and in-vitro functional verification.